NEW YORK, Jan 31 – Based on increased sales of its genomic mutation analysis tools, Omaha, Neb.-based Transgenomic reported increased revenues for the fourth quarter Wednesday, while losses decreased and expenses held steady.

The company reported fourth quarter revenues of $7.1 million, up 63 percent from revenues of $4.3 million in the third quarter of 1999.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

In Science this week: in vitro generation of human reproductive cells, and more.